Michael Janisiw

600 total citations
17 papers, 448 citations indexed

About

Michael Janisiw is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Janisiw has authored 17 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Janisiw's work include Platelet Disorders and Treatments (6 papers), Blood groups and transfusion (5 papers) and RNA regulation and disease (4 papers). Michael Janisiw is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Blood groups and transfusion (5 papers) and RNA regulation and disease (4 papers). Michael Janisiw collaborates with scholars based in Austria, United States and Germany. Michael Janisiw's co-authors include Michael F. Jantsch, Fabian Amman, Konstantin Licht, Markus Hartl, Dorothea Anrather, Simon Panzer, Peter Schlögelhofer, Kurt Huber, Marie-Therese Kurzbauer and Bernd Jilma and has published in prestigious journals such as Nucleic Acids Research, The Plant Cell and Genome biology.

In The Last Decade

Michael Janisiw

16 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Janisiw Austria	11	250	118	100	59	46	17	448
Gauthami Jalagadugula United States	10	66 0.3×	216 1.8×	57 0.6×	42 0.7×	8 0.2×	17	342
Jens Lohrmann Germany	9	154 0.6×	28 0.2×	40 0.4×	16 0.3×	100 2.2×	13	321
Lina Cordeddu Sweden	8	325 1.3×	20 0.2×	73 0.7×	24 0.4×	17 0.4×	12	418
J. Nico P. de Villiers South Africa	11	90 0.4×	135 1.1×	22 0.2×	33 0.6×	16 0.3×	20	373
Cecilia B. Levandowski United States	7	319 1.3×	18 0.2×	104 1.0×	116 2.0×	7 0.2×	12	470
Teodora Karan-Djurašević Serbia	12	185 0.7×	83 0.7×	13 0.1×	37 0.6×	6 0.1×	38	360
Kathrin Schwierczek Germany	4	63 0.3×	134 1.1×	44 0.4×	91 1.5×	5 0.1×	5	345
Philippa Burns United Kingdom	5	86 0.3×	112 0.9×	39 0.4×	52 0.9×	3 0.1×	8	256
Abraham Bayer United States	9	101 0.4×	151 1.3×	51 0.5×	89 1.5×	3 0.1×	18	366
Marcy Krumwiede United States	9	84 0.3×	165 1.4×	28 0.3×	60 1.0×	6 0.1×	20	394

Countries citing papers authored by Michael Janisiw

Since Specialization

Citations

This map shows the geographic impact of Michael Janisiw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Janisiw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Janisiw more than expected).

Fields of papers citing papers by Michael Janisiw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Janisiw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Janisiw. The network helps show where Michael Janisiw may publish in the future.

Co-authorship network of co-authors of Michael Janisiw

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Janisiw. A scholar is included among the top collaborators of Michael Janisiw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Janisiw. Michael Janisiw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Vries, Margreet R. de, et al.. (2022). Filamin A pre-mRNA editing modulates vascularization and tumor growth. Molecular Therapy — Nucleic Acids. 30. 522–534. 8 indexed citations

Kurzbauer, Marie-Therese, Michael Janisiw, Luis F. Paulin, et al.. (2021). ATM controls meiotic DNA double-strand break formation and recombination and affects synaptonemal complex organization in plants. The Plant Cell. 33(5). 1633–1656. 38 indexed citations

Ebner, Florian, et al.. (2020). An internal deletion of ADAR rescued by MAVS deficiency leads to a minute phenotype. Nucleic Acids Research. 48(6). 3286–3303. 38 indexed citations

Licht, Konstantin, Markus Hartl, Fabian Amman, et al.. (2018). Inosine induces context-dependent recoding and translational stalling. Nucleic Acids Research. 47(1). 3–14. 110 indexed citations

Kurzbauer, Marie-Therese, Mónica Pradillo, Claudia Kerzendorfer, et al.. (2018). Arabidopsis thaliana FANCD2 Promotes Meiotic Crossover Formation. The Plant Cell. 30(2). 415–428. 42 indexed citations

Tanzer, Andrea, Konstantin Licht, Michael T. Wolfinger, et al.. (2016). Transcriptome-wide effects of inverted SINEs on gene expression and their impact on RNA polymerase II activity. Genome biology. 17(1). 220–220. 16 indexed citations

Greisenegger, Stefan, Sonja Zehetmayer, Peter Bauer, et al.. (2008). Polymorphisms in Inflammatory Genes and the Risk of Ischemic Stroke and Transient Ischemic Attack: Results of a Multilocus Genotyping Assay. Clinical Chemistry. 55(1). 134–138. 24 indexed citations

Hsieh, Kety, Wolfgang Lalouschek, Martin Schillinger, et al.. (2005). Impact of αENaC Polymorphisms on the Risk of Ischemic Cerebrovascular Events: A Multicenter Case–Control Study. Clinical Chemistry. 51(6). 952–956. 9 indexed citations

Woelfer, B., K. Schuchter, Michael Janisiw, et al.. (2004). Postdelivery levels of anti‐D IgG prophylaxis in D– mothers depend on maternal body weight. Transfusion. 44(4). 512–517. 8 indexed citations

10.

Hsieh, Kety, Marion Funk, Martin Schillinger, et al.. (2004). Vienna Stroke Registry. Impact of the platelet glycoprotein Ib alpha Kozak polymorphism on the risk of ischemic cerebrovascular events. Blood Coagulation & Fibrinolysis. 15(6). 469–473. 12 indexed citations

11.

Dreesman, Johannes, et al.. (2003). Virushepatitis-Surveillance in Niedersachsen zur Erhebung von Risikofaktoren: Ergebnisse und Erfahrungen aus einem ÖGD-Regionalprojekt 1999-2001. Das Gesundheitswesen. 65(11). 653–658.

12.

Jilma‐Stohlawetz, Petra, Nicole Hergovich, Larisa Dzirlo, et al.. (2001). Impaired Platelet Function among Platelet Donors. Thrombosis and Haemostasis. 86(9). 880–886. 51 indexed citations

13.

Panzer, Simon, Michael Janisiw, Gottfried Fischer, & Bernd Jilma. (2000). The platelet α2-integrin (GPIa) nucleotide-807 polymorphism is not associated with a risk for maternal-fetal human platelet antigen-5 incompatibility. Annals of Hematology. 79(6). 296–298. 1 indexed citations

14.

Janisiw, Michael, et al.. (2000). Platelet Glycoprotein Ia Gene Dimorphism α2-807 in Malignant Arrhythmia in Coronary Artery Disease. Thrombosis Research. 98(4). 281–286. 17 indexed citations

15.

Janisiw, Michael. (2000). Calcaneal Ultrasound Attenuation and Vitamin-D-Receptor Genotypes in Celiac Disease. Scandinavian Journal of Gastroenterology. 35(2). 172–176. 20 indexed citations

16.

Sperr, Wolfgang R., Kurt Huber, Michael Roden, et al.. (1998). Inherited Platelet Glycoprotein Polymorphisms and a Risk for Coronary Heart Disease in Young Central Europeans. Thrombosis Research. 90(3). 117–123. 45 indexed citations

17.

Janisiw, Michael, et al.. (1998). Screening for platelet auto-antibodies by flow cytometry and their evaluation by the MAIPA technique.. PubMed. 110(15). 531–4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact